Urine liver-type fatty acid-binding protein predicts graft outcome up to 2 years after kidney transplantation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, J. | - |
dc.contributor.author | Choi, H. M. | - |
dc.contributor.author | Seo, M. Y. | - |
dc.contributor.author | Lee, J. Y. | - |
dc.contributor.author | Kim, K. | - |
dc.contributor.author | Jun, H. | - |
dc.contributor.author | Jung, C. W. | - |
dc.contributor.author | Park, K. T. | - |
dc.contributor.author | Kim, M. -G. | - |
dc.contributor.author | Jo, S. -K. | - |
dc.contributor.author | Cho, W. | - |
dc.contributor.author | Kim, H. K. | - |
dc.date.accessioned | 2022-07-16T05:33:05Z | - |
dc.date.available | 2022-07-16T05:33:05Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2014-03 | - |
dc.identifier.issn | 0041-1345 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/160398 | - |
dc.description.abstract | Background Several new biomarkers for the detection of early tubular injury have been investigated in kidney transplant recipients. We recently identified day 2 urinary neutrophil gelatinase-associated lipocalin (NGAL) as a predictor of slow graft function and adverse 1-year outcome. In the present study, we further investigated the value of urinary NGAL and liver-type fatty acid binding protein (L-FABP) for predicting long-term graft outcomes up to 2 years. Methods This study was a single-center, prospective observational study. Serial urinary NGAL and L-FABP levels at 0 hours, 2 days, and 6 days after kidney transplantation (KT) were measured, and the clinical data were assessed during the 2-year period after KT. Results During the 2-year follow-up period, 13 (18.8%), 5 (7.2%), and 4 (5.8%) patients were diagnosed with acute T-cell-mediated rejection, acute antibody-mediated rejection (AMR) and chronic AMR, respectively. In addition, 10 patients (14.3%) developed calcineurin inhibitor toxicity and 6 (8.7%) developed BK viremia. The mean estimated glomerular filtration rates (eGFR) at 1 and 2 years after KT were 65.1 ± 19.1 and 58.5 ± 22.6 mL/min/1.73 m2, respectively, When poor long-term graft function was defined as eGFR of less than 50 mL/min/1.73 m 2 at 2 years, elderly donors, acute rejection, and high 0-hour urinary L-FABP levels were significant risk factors. Furthermore, in rejection-free patients, L-FABP was strongly associated with poor long-term graft function (P =.006). Multivariate logistic regression analysis showed that high 0-hour L-FABP (P =.015) and acute rejection (P =.006) were independent factors predicting poor long-term graft function. Receiver operating characteristic analysis showed that the area under the curve for urinary L-FABP was 0.692 (P =.036). Conclusions Our results suggest that urinary L-FABP may be a useful predictor of adverse long-term outcomes in KT patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.title | Urine liver-type fatty acid-binding protein predicts graft outcome up to 2 years after kidney transplantation | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, H. M. | - |
dc.identifier.doi | 10.1016/j.transproceed.2013.11.130 | - |
dc.identifier.scopusid | 2-s2.0-84896441603 | - |
dc.identifier.wosid | 000333572100019 | - |
dc.identifier.bibliographicCitation | TRANSPLANTATION PROCEEDINGS, v.46, no.2, pp.376 - 380 | - |
dc.relation.isPartOf | TRANSPLANTATION PROCEEDINGS | - |
dc.citation.title | TRANSPLANTATION PROCEEDINGS | - |
dc.citation.volume | 46 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 376 | - |
dc.citation.endPage | 380 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalResearchArea | Transplantation | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.relation.journalWebOfScienceCategory | Transplantation | - |
dc.subject.keywordPlus | GELATINASE-ASSOCIATED LIPOCALIN | - |
dc.subject.keywordPlus | ACUTE ISCHEMIC-INJURY | - |
dc.subject.keywordPlus | RENAL-TRANSPLANTATION | - |
dc.subject.keywordPlus | ADVERSE OUTCOMES | - |
dc.subject.keywordPlus | CARDIAC-SURGERY | - |
dc.subject.keywordPlus | BIOMARKER | - |
dc.subject.keywordPlus | NGAL | - |
dc.subject.keywordPlus | NEPHROPATHY | - |
dc.subject.keywordPlus | DIALYSIS | - |
dc.subject.keywordPlus | DISEASE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.